GRPR and breast carcinoma: Additional cancer-specific targets are explored for imaging, such as gastrin-releasing peptide receptor (GRPR) imaging in breast cancer patients with ER-positive tumors using the receptor antagonist [68Ga]Ga-RM26 [74].